Copyright Reports & Markets. All rights reserved.

Global Eye Disorders Treatments Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Eye Disorders Treatments Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Cataract Surgery Devices
      • 1.4.3 Glaucoma Surgery Devices
      • 1.4.4 Vitreoretinal Surgery Devices
      • 1.4.5 Refractive Surgery Devices
    • 1.5 Market by Application
      • 1.5.1 Global Eye Disorders Treatments Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Eye Disorders Treatments Market Size
    • 2.2 Eye Disorders Treatments Growth Trends by Regions
      • 2.2.1 Eye Disorders Treatments Market Size by Regions (2014-2025)
      • 2.2.2 Eye Disorders Treatments Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Eye Disorders Treatments Market Size by Manufacturers
      • 3.1.1 Global Eye Disorders Treatments Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Eye Disorders Treatments Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Eye Disorders Treatments Market Concentration Ratio (CR5 and HHI)
    • 3.2 Eye Disorders Treatments Key Players Head office and Area Served
    • 3.3 Key Players Eye Disorders Treatments Product/Solution/Service
    • 3.4 Date of Enter into Eye Disorders Treatments Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Eye Disorders Treatments Market Size by Type (2014-2019)
    • 4.2 Global Eye Disorders Treatments Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Eye Disorders Treatments Market Size (2014-2019)
    • 5.2 Eye Disorders Treatments Key Players in United States
    • 5.3 United States Eye Disorders Treatments Market Size by Type
    • 5.4 United States Eye Disorders Treatments Market Size by Application

    6 Europe

    • 6.1 Europe Eye Disorders Treatments Market Size (2014-2019)
    • 6.2 Eye Disorders Treatments Key Players in Europe
    • 6.3 Europe Eye Disorders Treatments Market Size by Type
    • 6.4 Europe Eye Disorders Treatments Market Size by Application

    7 China

    • 7.1 China Eye Disorders Treatments Market Size (2014-2019)
    • 7.2 Eye Disorders Treatments Key Players in China
    • 7.3 China Eye Disorders Treatments Market Size by Type
    • 7.4 China Eye Disorders Treatments Market Size by Application

    8 Japan

    • 8.1 Japan Eye Disorders Treatments Market Size (2014-2019)
    • 8.2 Eye Disorders Treatments Key Players in Japan
    • 8.3 Japan Eye Disorders Treatments Market Size by Type
    • 8.4 Japan Eye Disorders Treatments Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Eye Disorders Treatments Market Size (2014-2019)
    • 9.2 Eye Disorders Treatments Key Players in Southeast Asia
    • 9.3 Southeast Asia Eye Disorders Treatments Market Size by Type
    • 9.4 Southeast Asia Eye Disorders Treatments Market Size by Application

    10 India

    • 10.1 India Eye Disorders Treatments Market Size (2014-2019)
    • 10.2 Eye Disorders Treatments Key Players in India
    • 10.3 India Eye Disorders Treatments Market Size by Type
    • 10.4 India Eye Disorders Treatments Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Eye Disorders Treatments Market Size (2014-2019)
    • 11.2 Eye Disorders Treatments Key Players in Central & South America
    • 11.3 Central & South America Eye Disorders Treatments Market Size by Type
    • 11.4 Central & South America Eye Disorders Treatments Market Size by Application

    12 International Players Profiles

    • 12.1 Abbott Medical Optics
      • 12.1.1 Abbott Medical Optics Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Eye Disorders Treatments Introduction
      • 12.1.4 Abbott Medical Optics Revenue in Eye Disorders Treatments Business (2014-2019)
      • 12.1.5 Abbott Medical Optics Recent Development
    • 12.2 Novartis
      • 12.2.1 Novartis Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Eye Disorders Treatments Introduction
      • 12.2.4 Novartis Revenue in Eye Disorders Treatments Business (2014-2019)
      • 12.2.5 Novartis Recent Development
    • 12.3 Alimera Sciences
      • 12.3.1 Alimera Sciences Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Eye Disorders Treatments Introduction
      • 12.3.4 Alimera Sciences Revenue in Eye Disorders Treatments Business (2014-2019)
      • 12.3.5 Alimera Sciences Recent Development
    • 12.4 Teva Pharmaceutical
      • 12.4.1 Teva Pharmaceutical Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Eye Disorders Treatments Introduction
      • 12.4.4 Teva Pharmaceutical Revenue in Eye Disorders Treatments Business (2014-2019)
      • 12.4.5 Teva Pharmaceutical Recent Development
    • 12.5 Eyetech Pharmaceuticals
      • 12.5.1 Eyetech Pharmaceuticals Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Eye Disorders Treatments Introduction
      • 12.5.4 Eyetech Pharmaceuticals Revenue in Eye Disorders Treatments Business (2014-2019)
      • 12.5.5 Eyetech Pharmaceuticals Recent Development
    • 12.6 Refocus Group
      • 12.6.1 Refocus Group Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Eye Disorders Treatments Introduction
      • 12.6.4 Refocus Group Revenue in Eye Disorders Treatments Business (2014-2019)
      • 12.6.5 Refocus Group Recent Development
    • 12.7 VisionCare Ophthalmic Technologies
      • 12.7.1 VisionCare Ophthalmic Technologies Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Eye Disorders Treatments Introduction
      • 12.7.4 VisionCare Ophthalmic Technologies Revenue in Eye Disorders Treatments Business (2014-2019)
      • 12.7.5 VisionCare Ophthalmic Technologies Recent Development
    • 12.8 VISX
      • 12.8.1 VISX Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Eye Disorders Treatments Introduction
      • 12.8.4 VISX Revenue in Eye Disorders Treatments Business (2014-2019)
      • 12.8.5 VISX Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Most treatment of eye diseases is aimed at reducing inflammation, repairing traumatic injuries and improving or saving eyesight.
      In 2018, the global Eye Disorders Treatments market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Eye Disorders Treatments status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Eye Disorders Treatments development in United States, Europe and China.

      The key players covered in this study
      Abbott Medical Optics
      Novartis
      Alimera Sciences
      Teva Pharmaceutical
      Eyetech Pharmaceuticals
      Refocus Group
      VisionCare Ophthalmic Technologies
      VISX

      Market segment by Type, the product can be split into
      Cataract Surgery Devices
      Glaucoma Surgery Devices
      Vitreoretinal Surgery Devices
      Refractive Surgery Devices

      Market segment by Application, split into
      Hospitals
      Clinics
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Eye Disorders Treatments status, future forecast, growth opportunity, key market and key players.
      To present the Eye Disorders Treatments development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Eye Disorders Treatments are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now